These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 913477)

  • 1. Proteases during the growth of Ehrlich ascites tumor. III. Effect of e-aminocaproic acid (EACA) and heparin.
    Back N; Leblanc PP
    Eur J Cancer (1965); 1977 Sep; 13(9):947-50. PubMed ID: 913477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Shock and its treatment with epsilon-aminocaproic acid (EACA)].
    Oswald W
    Acta Neuroveg (Wien); 1965; 27(3):369-77. PubMed ID: 5888051
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal susceptibility to cycloheximide of mice bearing Ehrlich ascites tumours and of animals pretreated with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1988 Oct; 99(3):309-15. PubMed ID: 3204165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. I. FIBRINOLYTIC SYSTEM, ASCITES RETENTION AND INTRAPERITONEAL HEMORRHAGE IN TUMOR BEARING MICE: SUPPRESSING EFFECT OF EPSILON AMINOCAPROIC ACID.
    KINJO K; HIRATA T; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():151-60. PubMed ID: 14160535
    [No Abstract]   [Full Text] [Related]  

  • 5. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells.
    Greeder GA; Milner JA
    Science; 1980 Aug; 209(4458):825-7. PubMed ID: 7406957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 Apr; 54(4):881-6. PubMed ID: 123966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated polyamine levels in erythrocytes of SLC:ICR mice inoculated with Ehrlich ascites carcinoma cells.
    Uehara N; Shirakawa S; Uchino H; Saeki Y; Nozaki M
    Life Sci; 1980 Feb; 26(6):461-7. PubMed ID: 7374356
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteases during the growth of Ehrlich ascites tumor. II. The kallikrein-kinin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 May; 54(5):1107-4. PubMed ID: 236396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental disseminated intravascular coagulation effect of heparin and epsilon-aminocaproic acid on tests of hemostatic function.
    Minn SK; Mandel EE
    Thromb Res; 1975 Mar; 6(3):235-46. PubMed ID: 1114490
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival time of mice bearing Ehrlich ascites tumor, with special reference to the effect of hydrocortisone administration.
    Kodama M; Amo H; Kodama T
    J Natl Cancer Inst; 1970 May; 44(5):1055-64. PubMed ID: 5514471
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of hydroxynitrodihydrothymine on the growth of Ehrlich ascites tumor cells.
    Mustea I; Bara A; Comes R; Postescu ID
    Cancer Treat Rep; 1978 May; 62(5):823-7. PubMed ID: 26466
    [No Abstract]   [Full Text] [Related]  

  • 13. Gossypol inhibits Ehrlich ascites tumor cell proliferation.
    Tso WW
    Cancer Lett; 1984 Oct; 24(3):257-61. PubMed ID: 6498805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cycloheximide, heparin and ancrod on mice given Ehrlich ascites tumour cells intravenously.
    Parry EW
    J Comp Pathol; 1985 Apr; 95(2):203-7. PubMed ID: 3837790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 16. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
    Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
    Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-nitrofuran derivatives on the uptake of labelled nucleic acids and protein precursors in the acid-insoluble fraction of Ehrlich ascites tumour cells.
    Fuska J; Fusková A; Jurásek A
    Neoplasma; 1973; 20(2):171-9. PubMed ID: 4707838
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by N-(phosphonacetyl)-L-aspartate of Ehrlich ascites tumour growth and glucose transport.
    Leung SW; Fung KP; Choy YM; Lee CY
    Cancer Lett; 1984 Jun; 23(2):183-8. PubMed ID: 6744243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells.
    El-Missiry MA; Abd El-Aziz AF
    Cancer Lett; 2000 Apr; 151(2):119-25. PubMed ID: 10738105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.